Lecanemab in Early Alzheimer's Disease. Reply
N Engl J Med
.
2023 Apr 27;388(17):1631-1632.
doi: 10.1056/NEJMc2301380.
Authors
Christopher H van Dyck
1
,
Marwan Sabbagh
2
,
Sharon Cohen
3
Affiliations
1
Yale School of Medicine, New Haven, CT christopher.vandyck@yale.edu.
2
Barrow Neurological Institute, Phoenix, AZ.
3
Toronto Memory Program, Toronto, ON, Canada.
PMID:
37099355
DOI:
10.1056/NEJMc2301380
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease*
Humans
Substances
lecanemab